lemilvo 15 mg
actavis ltd. - malta - aripiprazolum - compr. orodispersabile - 15mg - antipsihotice alte antipsihotice
aripiprazol accord healthcare 10 mg
actavis ltd. - malta - aripiprazolum - compr. orodispersabile - 10mg - antipsihotice alte antipsihotice
aripiprazol accord healthcare 15 mg
actavis ltd. - malta - aripiprazolum - compr. orodispersabile - 15mg - antipsihotice alte antipsihotice
perlinring 0,120 mg/0,015 mg/24 ore
warner chilcott uk ltd. - marea britanie - combinatii (etonogestrelum+etinilestradiolum) - sist. cu cedare vaginala - 0,120mg/0,015mg/24ore - contraceptive locale contraceptive intravaginale
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - mielom multiplu - agenți antineoplazici - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
amotin
medmac, iordania - amoxycillin(trihydrate), - pulbere pentru administrare in apa de băut
firazyr
takeda pharmaceuticals international ag - icatibant - angioedem, ereditar - terapia cardiacă - firazyr este indicat pentru tratamentul simptomatic al atacurilor acute de angioedem ereditar (hae) la adulți (cu deficiență de inhibitor de c1-esterază).
ruconest
pharming group n.v. - uman recombinant c1-inhibitor - angioedem, ereditar - drugs used in hereditary angioedema, other hematological agents - ruconest este indicat pentru tratamentul atacurilor acute de angioedem în adulţi cu angioedemul ereditar (aee) din cauza deficienta de c1-inhibitor esterazei.
doxetyl® wsp, pulbere administrată pe cale orală
medmac, iordania - doxiciclină - pulbere orală
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, ereditar - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.